ArticleInternational urology and nephrology2026
Research trends and hotspots of kidney disease and stem cell therapy from 2009 to 2025: a bibliometric analysis.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial: Stem cells and kidney regeneration: transforming renal medicine.Frontiers in bioengineering and biotechnology · 2025Article
- Ultrasound-guided intrarenal arterial injection promotes homing of MSCs and recovery of kidney in Adriamycin-induced nephropathy in rats.Cell transplantationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDespite the growing interest in stem cell therapy for kidney disease research, there remains a lack of comprehensive and systematic bibliometric analyses in this field. This study aimed to summarize the progress in stem cell therapy for kidney disease through bibliometric analysis, providing insights into the development and direction of the field.
methodsPublications related to kidney disease and stem cell therapy in the last 17 years were retrieved from the Web of Science Core Collection (WOSCC) database on July 15, 2025. In conducting a comprehensive bibliometric analysis, a variety of bibliographic elements were meticulously collected to map the landscape of research within a specific field.
resultsBetween January 1, 2009, and July 15, 2025, a total of 3,914 articles on stem cell therapy research in kidney disease were published across 186 academic journals by 19,195 authors from 3906 institutions in 90 countries. The volume of publications has shown a steady increase over this period. The United States and China lead in both publication and citation counts. Harvard University and University of California System are the most active institutions in this research domain. Lilach O. Lerman from the Mayo Clinic College of Medicine and Science was noted for the highest number of significant publications and received the most co-citations. The analysis revealed key research themes, including pluripotent stem cells, exosomes, and extracellular vesicles.
conclusionThis study provided a comprehensive bibliometric and knowledge mapping analysis of stem cell therapy in kidney disease research landscape, offering valuable insights into the trends, key contributors, and thematic focus areas within the field. By delineating the evolution of this research, this study aims to guide future scholarly endeavors and enhance our understanding of stem cell therapeutic potential.
Indexed as
Identifiers
40839058What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.